ReviewPharmaceutics2020
Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases.
Yujie Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
53 papers cite it
this paperpooled itcites it